Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza in Congestive Heart Failure
NCT00944229Phase 3Terminated
- Sponsor
- Columbia University
- Start
- Jan 2010
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid, sponsored by Columbia University. Started Jan 2010; status: terminated.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
Beyond the preview
Go deeper on NCT00944229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944229.